ArticleEuropean journal of nuclear medicine and molecular imaging2023

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml.

Nantia Solomonidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.